Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

United States Biologics and Biosimilars Market Report 2016

Posted on: 12 Oct 16
United States Biologics and Biosimilars Market Report 2016

Report Summary :

This report studies sales (consumption) of Biologics and Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Download Report Sample @

Table of Contents

United States Biologics and Biosimilars Market Report 2016
1 Biologics and Biosimilars Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.2.1 Classification by Technology
1.2.2 Classification by Types
1.2.3 Classification by Use
1.2.4 Classification by Services
1.3 Application of Biologics and Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biologics and Biosimilars (2011-2021)
1.4.1 United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)
1.4.2 United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

For More Details VISIT @


Contact Us

New York City Zone 01,
NY, United States.
Int'l: (+1) 646 781 7170




Editor's Details

Angela Wattson
(+1) 646 781 7170

Last updated on: 12/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.